Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Morphologic and Molecular Features of Breast Ductal Carcinoma In Situ.

Sanati S.

Am J Pathol. 2018 Oct 29. pii: S0002-9440(18)30408-5. doi: 10.1016/j.ajpath.2018.07.031. [Epub ahead of print] Review.

PMID:
30385094
2.

Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast.

Vranic S, Palazzo J, Sanati S, Florento E, Contreras E, Xiu J, Swensen J, Gatalica Z.

Clin Breast Cancer. 2018 Sep 5. pii: S1526-8209(18)30321-5. doi: 10.1016/j.clbc.2018.09.001. [Epub ahead of print]

3.

Ultrasound-assisted synthesis of NiFe- layered double hydroxides as efficient electrode materials in supercapacitors.

Sanati S, Rezvani Z.

Ultrason Sonochem. 2018 Nov;48:199-206. doi: 10.1016/j.ultsonch.2018.05.035. Epub 2018 May 29.

PMID:
30080543
4.

A review of the effects of Capsicum annuum L. and its constituent, capsaicin, in metabolic syndrome.

Sanati S, Razavi BM, Hosseinzadeh H.

Iran J Basic Med Sci. 2018 May;21(5):439-448. doi: 10.22038/IJBMS.2018.25200.6238. Review.

5.

Salivary Duct Carcinoma and Invasive Ductal Carcinoma of the Breast: A Comparative Immunohistochemical Study.

Jalaly JB, Sanati S, Chernock RD, Dibe DG, El-Mofty SK.

Head Neck Pathol. 2018 Dec;12(4):488-492. doi: 10.1007/s12105-017-0882-2. Epub 2018 Jan 4.

PMID:
29302899
6.

Anticancer, antibacterial and antifungal activity of new ni (ii) and cu (ii) complexes of imidazole-phenanthroline derivatives.

Moghadam ME, Divsalar A, Zare MS, Gholizadeh R, Mahalleh D, Saghatforosh L, Sanati S.

Nucleosides Nucleotides Nucleic Acids. 2017 Nov 2;36(11):667-675. doi: 10.1080/15257770.2017.1388393. Epub 2017 Nov 29.

PMID:
29185856
7.

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.

Bagegni N, Thomas S, Liu N, Luo J, Hoog J, Northfelt DW, Goetz MP, Forero A, Bergqvist M, Karen J, Neumüller M, Suh EM, Guo Z, Vij K, Sanati S, Ellis M, Ma CX.

Breast Cancer Res. 2017 Nov 21;19(1):123. doi: 10.1186/s13058-017-0913-7.

8.

Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.

Gabani P, Cyr AE, Zoberi JE, Ochoa LL, Matesa MA, Thomas MA, Garcia J, Margenthaler JA, Naughton MJ, Ma C, Sanati S, Zoberi I.

Brachytherapy. 2018 Jan - Feb;17(1):171-180. doi: 10.1016/j.brachy.2017.09.009. Epub 2017 Oct 28.

PMID:
29089275
9.

A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer.

Ma CX, Suman V, Goetz MP, Northfelt D, Burkard ME, Ademuyiwa F, Naughton M, Margenthaler J, Aft R, Gray R, Tevaarwerk A, Wilke L, Haddad T, Moynihan T, Loprinzi C, Hieken T, Barnell EK, Skidmore ZL, Feng YY, Krysiak K, Hoog J, Guo Z, Nehring L, Wisinski KB, Mardis E, Hagemann IS, Vij K, Sanati S, Al-Kateb H, Griffith OL, Griffith M, Doyle L, Erlichman C, Ellis MJ.

Clin Cancer Res. 2017 Nov 15;23(22):6823-6832. doi: 10.1158/1078-0432.CCR-17-1260. Epub 2017 Sep 5.

10.

Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer.

Goncalves R, DeSchryver K, Ma C, Tao Y, Hoog J, Cheang M, Crouch E, Dahiya N, Sanati S, Barnes M, Sarian LOZ, Olson J, Allred DC, Ellis MJ.

Breast Cancer Res Treat. 2017 Sep;165(2):355-364. doi: 10.1007/s10549-017-4329-y. Epub 2017 Jun 13.

11.

The role of skin ulceration in breast carcinoma staging and outcome.

Khoury T, Gaudioso C, Fang YV, Sanati S, Opyrchal M, Desouki MM, Karabakhtsian RG, Li Z, Wang D, Yan L, Jacobson R.

Breast J. 2018 Jan;24(1):41-50. doi: 10.1111/tbj.12830. Epub 2017 Jun 8.

PMID:
28597587
12.

Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.

Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Townsend RR, Chen X, Carr SA, Ellis MJ, Ding L.

Nat Commun. 2017 Apr 25;8:15479. doi: 10.1038/ncomms15479. No abstract available.

13.

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.

Huang KL, Li S, Mertins P, Cao S, Gunawardena HP, Ruggles KV, Mani DR, Clauser KR, Tanioka M, Usary J, Kavuri SM, Xie L, Yoon C, Qiao JW, Wrobel J, Wyczalkowski MA, Erdmann-Gilmore P, Snider JE, Hoog J, Singh P, Niu B, Guo Z, Sun SQ, Sanati S, Kawaler E, Wang X, Scott A, Ye K, McLellan MD, Wendl MC, Malovannaya A, Held JM, Gillette MA, Fenyö D, Kinsinger CR, Mesri M, Rodriguez H, Davies SR, Perou CM, Ma C, Reid Townsend R, Chen X, Carr SA, Ellis MJ, Ding L.

Nat Commun. 2017 Mar 28;8:14864. doi: 10.1038/ncomms14864.

14.

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.

Ma CX, Gao F, Luo J, Northfelt DW, Goetz M, Forero A, Hoog J, Naughton M, Ademuyiwa F, Suresh R, Anderson KS, Margenthaler J, Aft R, Hobday T, Moynihan T, Gillanders W, Cyr A, Eberlein TJ, Hieken T, Krontiras H, Guo Z, Lee MV, Spies NC, Skidmore ZL, Griffith OL, Griffith M, Thomas S, Bumb C, Vij K, Bartlett CH, Koehler M, Al-Kateb H, Sanati S, Ellis MJ.

Clin Cancer Res. 2017 Aug 1;23(15):4055-4065. doi: 10.1158/1078-0432.CCR-16-3206. Epub 2017 Mar 7.

15.

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).

Ellis MJ, Suman VJ, Hoog J, Goncalves R, Sanati S, Creighton CJ, DeSchryver K, Crouch E, Brink A, Watson M, Luo J, Tao Y, Barnes M, Dowsett M, Budd GT, Winer E, Silverman P, Esserman L, Carey L, Ma CX, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther JM, Dayao Z, Ota D, Leitch M, Olson JA Jr, Allred DC, Hunt K.

J Clin Oncol. 2017 Apr 1;35(10):1061-1069. doi: 10.1200/JCO.2016.69.4406. Epub 2017 Jan 3.

16.

Axillary Ultrasound Accurately Excludes Clinically Significant Lymph Node Disease in Patients With Early Stage Breast Cancer.

Tucker NS, Cyr AE, Ademuyiwa FO, Tabchy A, George K, Sharma PK, Jin LX, Sanati S, Aft R, Gao F, Margenthaler JA, Gillanders WE.

Ann Surg. 2016 Dec;264(6):1098-1102.

17.

Lymphovascular space invasion and lack of downstaging after neoadjuvant chemotherapy are strong predictors of adverse outcome in young women with locally advanced breast cancer.

Khwaja SS, Ivanovich J, DeWees TA, Ochoa L, Mullen DF, Thomas M, Margenthaler JA, Cyr A, Naughton M, Sanati S, Eberlein TJ, Gillanders WE, Aft RL, Zoberi JE, Zoberi I.

Cancer Med. 2016 Feb;5(2):230-8. doi: 10.1002/cam4.586. Epub 2015 Dec 21.

18.

Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.

Gatalica Z, Vranic S, Ghazalpour A, Xiu J, Ocal IT, McGill J, Bender RP, Discianno E, Schlum A, Sanati S, Palazzo J, Reddy S, Pockaj B.

Oncotarget. 2016 Jan 12;7(2):1707-16. doi: 10.18632/oncotarget.6421.

19.

Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions.

Khoury T, Kumar PR, Li Z, Karabakhtsian RG, Sanati S, Chen X, Wang D, Liu S, Reig B.

Mod Pathol. 2016 Jan;29(1):25-33. doi: 10.1038/modpathol.2015.128. Epub 2015 Nov 13.

20.

The risk of upgrade for atypical ductal hyperplasia detected on magnetic resonance imaging-guided biopsy: a study of 100 cases from four academic institutions.

Khoury T, Li Z, Sanati S, Desouki MM, Chen X, Wang D, Liu S, Karabakhtsian R, Kumar P, Reig B.

Histopathology. 2016 Apr;68(5):713-21. doi: 10.1111/his.12811. Epub 2015 Oct 5.

21.

Synthesis of zinc hydroxide nanocrystals and application as a new electrochemical sensor for determination of selected sympathomimetic drugs.

Saghatforoush LA, Mehdizadeh R, Sanati S, Hasanzadeh M.

Acta Chim Slov. 2012 Dec;59(4):863-9.

PMID:
24061369
22.

Improved laboratory resource utilization and patient care with the use of rapid on-site evaluation for endobronchial ultrasound fine-needle aspiration biopsy.

Collins BT, Chen AC, Wang JF, Bernadt CT, Sanati S.

Cancer Cytopathol. 2013 Oct;121(10):544-51. doi: 10.1002/cncy.21320. Epub 2013 Jul 3.

23.

Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens.

Sanati S, Huettner P, Ylagan LR.

Int J Gynecol Pathol. 2010 Jan;29(1):79-87. doi: 10.1097/PGP.0b013e3181ae81a0.

PMID:
19952938
24.

Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.

Sanati S, Watson MA, Salavaggione AL, Humphrey PA.

Mod Pathol. 2009 Oct;22(10):1273-9. doi: 10.1038/modpathol.2009.103. Epub 2009 Jul 24.

25.

Cytologic diagnosis of Ewing sarcoma/peripheral neuroectodermal tumor with paired prospective molecular genetic analysis.

Sanati S, Lu DW, Schmidt E, Perry A, Dehner LP, Pfeifer JD.

Cancer. 2007 Jun 25;111(3):192-9.

26.
27.

Nodular mucinosis of the breast: a case report with pathologic, ultrasonographic, and clinical findings and review of the literature.

Sanati S, Leonard M, Khamapirad T, Eltorky MA.

Arch Pathol Lab Med. 2005 Mar;129(3):e58-61. Review.

PMID:
15737051
28.

Lymphoepithelioma-like carcinoma of the breast: report of a case mimicking lymphoma.

Sanati S, Ayala AG, Middleton LP.

Ann Diagn Pathol. 2004 Oct;8(5):309-15.

PMID:
15494940
29.

Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice.

Naghavi M, Wyde P, Litovsky S, Madjid M, Akhtar A, Naguib S, Siadaty MS, Sanati S, Casscells W.

Circulation. 2003 Feb 11;107(5):762-8.

PMID:
12578882

Supplemental Content

Loading ...
Support Center